Human milk oligosaccharides (HMOs) are a family of structurally diverse unconjugated glycan’s that are found in and unique to human breast milk, despite not actually being digestible by human infants. HMOs function as a prebiotic helping to establish commensal bacteria. HMOs also function as anti-adhesives that help prevent the attachment of microbial pathogens to mucosal surfaces. Human milk oligosaccharides are manufactured through numerous processes which involve the use of several chemicals, enzymes or microbes. The technology used for manufacturing of human milk oligosaccharides is very complex and expensive, thus restricting their large-scale production. Major players have been increasing investing increasingly on R&D for low-cost production and the introduction of effective technologies for product synthesis.
According to our (Global Info Research) latest study, the global Human Milk Oligosaccharides (HMO) market size was valued at USD 396 million in 2022 and is forecast to a readjusted size of USD 1015.7 million by 2029 with a CAGR of 14.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Get Free Sample Report @ https://www.globalinforesearch.com/reports/1003739/human-milk-oligosaccharides-(hmo)
Global core human milk oligosaccharides (HMO) manufacturers include Abbott, Glycom etc.The top 2 companies hold a share about 70%. North America is the largest market, with a share about 45%, followed by Europe and China with the share about 32% and 10%.In terms of product, 2'-FL & 3-FL is the largest segment, with a share over 95%. And in terms of application, the largest application is infant formula.
This report is a detailed and comprehensive analysis for global Human Milk Oligosaccharides (HMO) market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Market segment by Type
2'-FL & 3-FL
Sialyllactose
LNT & LNnT
Market segment by Application
Infant Formula
Functional Food & Beverages
Food/Medical Supplements
Others
Major players covered
Abbott
Inbiose
Glycom
Chr. Hansen (Jennewein)
ZuChem
Glycom
About US
Global Info Research is a report publisher, a customer, interest-based suppliers. Is in the best interests of our clients, they determine our every move. At the same time, we have great respect for the views of customers. With the improvement of the quality of our research, we develop custom interdisciplinary and comprehensive solution. For further development, we will do better and better. GlobalInfoResearch will with excellent professional knowledge and experience to carry out all aspects of our business. At the same time, we will thoroughly look for information, to give a more comprehensive development.
Contact US
Global Info Research
E-mail: report@globalinforesearch.com
Tel: +86-17665052062 00852-58197708(HK)
WeChat: 17665052062
Add:FLAT/RM A 9/F SILVERCORP INTERNATIONAL TOWER 707-713 NATHAN ROAD MONGKOK KL HONG KONG
Website: http://www.globalinforesearch.com
